San Francisco Examiner, May 5, 1999
Gregory Lewis and Ulysses Torassa of the Examiner Staff
The mayor hopes the program, which he announced Tuesday as another way to stem the spread of HIV and AIDS, will encourage other businesses to contribute a total of $5 million over the same time period.
Despite breakthroughs in AIDS research, treatment, education and prevention, Brown said: "There's been an increase in the number of people infected, particularly in communities of color. The education and information has not penetrated (there) the way it should have."
DuPont President Nicholas Teti, who participated in the program's announcement, said: "Adequate funding often turns a new idea into a successful idea. DuPont's $1 million grant sets the initiative on the path to success. We're inviting other businesses in San Francisco to help us raise $5 million."
Brown said at least two companies have expressed interest in contributing. AIDS activists weren't necessarily overjoyed by the news.
When word spread last year that DuPont's new AIDS drug Sustiva would cost much more than other drugs in its class, activists formed a Fair Price Coalition and went to the company's headquarters to try to persuade DuPont to reconsider.
They had little success, according to Linda Grinberg, a member of the coalition and a Los Angeles AIDS activist.
Teti acknowledged the controversy surrounding the price of Sustiva but said, "We felt that it was priced extremely fair."
City officials say the money raised from the program could make a lot of difference to their prevention programs, which now have an $11 million a year budget.
990505
SE990502
Copyright © 1999 - San Francisco Examiner. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Examiner, Permissions Desk, 110 Fifth Street, P.O. Box 7260, San Franciso, CA 94120.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .